Dark patches on the cheekbones are one of the most common locations for facial hyperpigmentation, and the most likely explanation is melasma, a condition driven by sun exposure and hormonal changes. The cheekbone area sits high on the face where it catches the most UV light, making it especially prone to excess pigment production. Other possibilities include darkening left behind from acne or irritation, sun spots, or a deeper pigment condition called Hori’s nevus.
Melasma: The Most Common Cause
Melasma appears as flat, symmetrical brown or grayish-brown patches, usually on both cheekbones at once. It affects up to 50 to 80% of people with the condition in what dermatologists call the “centrofacial” pattern, which spans the forehead, cheeks, nose, and upper lip. A purely malar pattern, limited mostly to the cheeks and nose, accounts for about 20% of cases. The patches have irregular borders, aren’t raised, and don’t itch or hurt.
What makes melasma different from a simple sunburn or tan is that it reflects chronic, cumulative sun damage at the cellular level. UV exposure is the single biggest trigger, but genetics play a nearly equal role. If a close relative has melasma, your risk goes up significantly. The condition is also far more common in people with medium to dark skin tones, though it can affect anyone.
How Hormones Darken the Cheeks
Hormonal shifts are the second major driver, which is why melasma often appears during pregnancy, while taking birth control pills, or during hormone replacement therapy. Estrogen binds to receptors on pigment-producing cells in the skin and directly ramps up the production of enzymes responsible for making melanin. Skin affected by melasma actually has a higher concentration of estrogen receptors than surrounding normal skin, which helps explain why the darkening targets specific zones rather than the whole face.
Progesterone adds to the problem through a separate signaling pathway. It activates a master regulator of melanocyte activity, essentially telling pigment cells to work harder and produce more melanin. This dual hormonal effect is why melasma so frequently worsens during the second and third trimesters of pregnancy, when both estrogen and progesterone levels peak.
Post-Inflammatory Hyperpigmentation
If your cheekbone darkening developed after a breakout, an allergic reaction, eczema, or any kind of skin irritation in that area, you may be dealing with post-inflammatory hyperpigmentation (PIH). This happens when inflammation triggers pigment cells to overproduce melanin or distribute it unevenly. The dark marks follow the exact footprint of whatever caused the inflammation, so if you had a cluster of acne on one cheekbone, the darkening will map to that same spot.
PIH is especially common in darker skin tones. Unlike melasma, it’s usually not symmetrical. It can also result from overly aggressive skincare, like harsh scrubbing or strong chemical exfoliants applied too frequently. Repeated friction from any source, whether it’s vigorous towel drying, abrasive scrub pads, or even the nose pads of heavy glasses pressing into the upper cheeks, can trigger localized darkening over time.
Hori’s Nevus: A Deeper Pigment Condition
A less common but important possibility is Hori’s nevus, also called acquired bilateral nevus of Ota-like macules. This condition looks similar to melasma on the surface: symmetrical gray-brown or blue-gray spots on the cheekbones. The key difference is where the pigment sits. In melasma, excess melanin is mostly in the upper layers of skin. In Hori’s nevus, pigment is deposited deeper in the dermis, giving it a slightly more bluish or slate-gray tone.
Distinguishing the two matters because they respond differently to treatment. A study comparing dermatoscopic features in 96 patients found that light brown pigmentation appeared in 98% of melasma cases but only about 11% of Hori’s nevus cases. Hori’s nevus instead showed a speckled pattern in over half of cases that was absent in melasma entirely. If your cheekbone darkening has a grayish or bluish tint rather than a warm brown, it’s worth having a dermatologist take a closer look.
Why the Cheekbones Specifically
The cheekbones are a high point of the face, meaning they receive more direct UV exposure than recessed areas like the temples or under the eyes. This makes them a natural hotspot for sun-driven pigmentation. The skin over the cheekbones is also relatively thin compared to the forehead and chin, with less subcutaneous fat to buffer the effects of UV and visible light. For people who wear sunglasses, the area just below or around the frames often gets inconsistent protection, creating a zone of concentrated exposure.
Heat is another underappreciated factor. Activities like cooking over a stove, sitting close to a fireplace, or spending extended time in hot environments can worsen pigmentation in sun-exposed areas. This is sometimes called thermal melasma, and the cheekbones are a primary target because of their prominence.
What Helps Fade Cheekbone Darkening
Topical treatments are the first-line approach for most causes of cheekbone hyperpigmentation. The two most studied options are hydroquinone at 2 to 4% concentration and azelaic acid at 20%. Multiple clinical trials have compared these head-to-head over treatment periods ranging from 8 to 24 weeks, and both produce meaningful fading. Azelaic acid tends to be better tolerated, while hydroquinone typically works faster but can cause irritation. In every study, consistent daily sunscreen use was part of the protocol, not optional.
Other effective ingredients include vitamin C, which interferes with melanin production, and retinoids, which speed up skin cell turnover so pigmented cells are shed more quickly. Niacinamide (a form of vitamin B3) helps by blocking the transfer of melanin from pigment cells to surrounding skin cells. Improvements from topical treatments generally become visible around week 2, with continued fading through week 12 and beyond. Dark spot size, intensity, and contrast all improve, but the timeline requires patience.
Professional Treatments
For stubborn or deep pigmentation, dermatologists may recommend chemical peels or laser therapy. The most commonly used laser for cheekbone pigmentation is the Q-switched Nd:YAG at 1064 nm, which targets melanin deep in the skin while causing minimal damage to the surface. Fractional lasers at 1550 nm can also reach dermal pigment by treating tiny columns of skin rather than the entire surface.
Laser treatment for facial pigmentation carries real risks. Low-fluence laser toning can sometimes cause white spots (hypopigmentation) that may be permanent. One study using non-ablative fractional laser found that 31% of patients actually developed new darkening afterward. This is why lasers are generally reserved for cases that haven’t responded to topical therapy, and why choosing an experienced provider matters significantly.
Sunscreen Alone May Not Be Enough
Standard UV-blocking sunscreens protect against the ultraviolet rays that trigger pigmentation, but visible light (the kind you can see) also stimulates melanin production, particularly in medium to dark skin tones. A recent study found that sunscreens containing iron oxides successfully prevented visible light-induced darkening in people with Fitzpatrick skin type IV, while a standard SPF 50+ sunscreen without iron oxides could not. If you’re prone to cheekbone darkening, look for tinted sunscreens or mineral formulas that list iron oxides in the ingredients. These appear tinted because the iron oxides physically block visible light wavelengths.
Reapplication matters as much as the formula itself. In clinical trials studying pigmentation treatments, participants were instructed to reapply sunscreen every 3 hours during daylight. A single morning application, even at SPF 50, won’t hold up through a full day of sun exposure. Broad-brimmed hats provide an additional layer of protection that’s especially effective for the cheekbone area, since the brim casts a shadow directly over the malar region.